There are four NPY receptors in humans and they are designated as Y1, Y2, Y4, and Y5
Studies show the compound crosses the blood-brain barrier efficiently despite its peptide structure, achieving central nervous system concentrations sufficient for biological activity following systemic administration
It stimulates both the GLP-1 and GIP receptors: it mimics the naturally present hormone and reduces gastric emptying while inducing more insulin secretion
Expert discovery is scheduled to be completed by March 27, 2026, with motions for summary judgment due April 16, 2026, followed by preparations for the first bellwether trials
Lunch is a Mediterranean plate with grilled chicken, cucumber, tomatoes, olives, and feta cheese
GLP-1 agonist signaling